Nutritional Interventions for the Prevention of Cognitive Decline in Patients With Mild Cognitive Impairment and Alzheimer Disease: Protocol for a Network Meta-Analysis of Randomized Controlled Trials
BackgroundMild cognitive impairment (MCI) is the stage between cognitive decline due to physiological aging and the severity of decline seen in neurodegenerative disorders like Alzheimer disease (AD), which is among the most prevalent neurodegenerative disorders characterized...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
JMIR Publications
2024-02-01
|
Series: | JMIR Research Protocols |
Online Access: | https://www.researchprotocols.org/2024/1/e47196 |
_version_ | 1797292572812509184 |
---|---|
author | Qian He Kevin Chun Hei Wu Adam N Bennett Jia Yue Zhang Kei Hang Katie Chan |
author_facet | Qian He Kevin Chun Hei Wu Adam N Bennett Jia Yue Zhang Kei Hang Katie Chan |
author_sort | Qian He |
collection | DOAJ |
description |
BackgroundMild cognitive impairment (MCI) is the stage between cognitive decline due to physiological aging and the severity of decline seen in neurodegenerative disorders like Alzheimer disease (AD), which is among the most prevalent neurodegenerative disorders characterized by cognitive impairment. People with MCI are at increased risk of developing AD. Although MCI and AD are incurable, nutritional interventions can potentially delay or prevent their onset. Consequently, effective interventions used to decelerate or alleviate the progress of cognitive impairment in older people are a significant focus in geriatric care. Given the synergistic effects of nutrition on health, assessing the effectiveness of nutritional supplements or dietary composition in preventing MCI or AD is essential for developing interventional strategies.
ObjectiveOur study aims to assess the effectiveness of various nutritional interventions, including special dietary types, dietary patterns, specific foods, nutritional intake, and nutritional supplements, in preventing cognitive decline among patients diagnosed with MCI or AD. To achieve this, we will use a comprehensive approach, including network meta-analysis, pairwise meta-analysis, and systematic review of randomized controlled trials (RCTs).
MethodsThe review will follow the Population, Intervention, Comparison, Outcome (PICO) model and the PRISMA-P (Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols) guidelines. Two investigators will independently search PubMed electronically. Data extraction will follow the inclusion criteria, and data will be assessed for risk of bias using a revised tool. Additionally, evidence quality will be evaluated using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) framework. The outcomes of interest are assessing the cognitive outcomes in patients with MCI or AD. A systematic literature search will be conducted, identifying randomized controlled trials that investigate the impact of these nutritional interventions on cognitive function decline in individuals with MCI and AD. Network meta-analyses (random-effects model) and pairwise meta-analyses will then estimate the relative effectiveness of different nutritional interventions.
ResultsWe included 51 studies, published between 1999 and 2023 (27 studies for AD and 24 studies for MCI) and involving 8420 participants. We completed data extraction for all 51 studies by December 2023. Currently, we are actively engaged in data analysis and manuscript preparation. We plan to finalize the manuscript and publish the comprehensive results by the end of 2024.
ConclusionsOur study holds significant clinical relevance given the rising prevalence of AD and the potential influence of nutritional interventions on cognitive function in individuals with MCI and AD. By investigating this relationship, our research aims to inform evidence-based decision-making in the development of prevention strategies for MCI and AD. The outcomes are expected to contribute to the establishment of reliable recommendations for MCI or AD management, providing substantial support in the field.
Trial RegistrationPROSPERO CRD42022331173; http://tinyurl.com/3snjp7a4
International Registered Report Identifier (IRRID)PRR1-10.2196/47196 |
first_indexed | 2024-03-07T19:58:24Z |
format | Article |
id | doaj.art-c97b3ad275724303a4e983f90d06f3d8 |
institution | Directory Open Access Journal |
issn | 1929-0748 |
language | English |
last_indexed | 2024-03-07T19:58:24Z |
publishDate | 2024-02-01 |
publisher | JMIR Publications |
record_format | Article |
series | JMIR Research Protocols |
spelling | doaj.art-c97b3ad275724303a4e983f90d06f3d82024-02-28T13:30:31ZengJMIR PublicationsJMIR Research Protocols1929-07482024-02-0113e4719610.2196/47196Nutritional Interventions for the Prevention of Cognitive Decline in Patients With Mild Cognitive Impairment and Alzheimer Disease: Protocol for a Network Meta-Analysis of Randomized Controlled TrialsQian Hehttps://orcid.org/0000-0003-4346-9899Kevin Chun Hei Wuhttps://orcid.org/0009-0003-5570-155XAdam N Bennetthttps://orcid.org/0000-0001-8307-327XJia Yue Zhanghttps://orcid.org/0009-0007-4362-8702Kei Hang Katie Chanhttps://orcid.org/0000-0001-9070-5394 BackgroundMild cognitive impairment (MCI) is the stage between cognitive decline due to physiological aging and the severity of decline seen in neurodegenerative disorders like Alzheimer disease (AD), which is among the most prevalent neurodegenerative disorders characterized by cognitive impairment. People with MCI are at increased risk of developing AD. Although MCI and AD are incurable, nutritional interventions can potentially delay or prevent their onset. Consequently, effective interventions used to decelerate or alleviate the progress of cognitive impairment in older people are a significant focus in geriatric care. Given the synergistic effects of nutrition on health, assessing the effectiveness of nutritional supplements or dietary composition in preventing MCI or AD is essential for developing interventional strategies. ObjectiveOur study aims to assess the effectiveness of various nutritional interventions, including special dietary types, dietary patterns, specific foods, nutritional intake, and nutritional supplements, in preventing cognitive decline among patients diagnosed with MCI or AD. To achieve this, we will use a comprehensive approach, including network meta-analysis, pairwise meta-analysis, and systematic review of randomized controlled trials (RCTs). MethodsThe review will follow the Population, Intervention, Comparison, Outcome (PICO) model and the PRISMA-P (Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols) guidelines. Two investigators will independently search PubMed electronically. Data extraction will follow the inclusion criteria, and data will be assessed for risk of bias using a revised tool. Additionally, evidence quality will be evaluated using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) framework. The outcomes of interest are assessing the cognitive outcomes in patients with MCI or AD. A systematic literature search will be conducted, identifying randomized controlled trials that investigate the impact of these nutritional interventions on cognitive function decline in individuals with MCI and AD. Network meta-analyses (random-effects model) and pairwise meta-analyses will then estimate the relative effectiveness of different nutritional interventions. ResultsWe included 51 studies, published between 1999 and 2023 (27 studies for AD and 24 studies for MCI) and involving 8420 participants. We completed data extraction for all 51 studies by December 2023. Currently, we are actively engaged in data analysis and manuscript preparation. We plan to finalize the manuscript and publish the comprehensive results by the end of 2024. ConclusionsOur study holds significant clinical relevance given the rising prevalence of AD and the potential influence of nutritional interventions on cognitive function in individuals with MCI and AD. By investigating this relationship, our research aims to inform evidence-based decision-making in the development of prevention strategies for MCI and AD. The outcomes are expected to contribute to the establishment of reliable recommendations for MCI or AD management, providing substantial support in the field. Trial RegistrationPROSPERO CRD42022331173; http://tinyurl.com/3snjp7a4 International Registered Report Identifier (IRRID)PRR1-10.2196/47196https://www.researchprotocols.org/2024/1/e47196 |
spellingShingle | Qian He Kevin Chun Hei Wu Adam N Bennett Jia Yue Zhang Kei Hang Katie Chan Nutritional Interventions for the Prevention of Cognitive Decline in Patients With Mild Cognitive Impairment and Alzheimer Disease: Protocol for a Network Meta-Analysis of Randomized Controlled Trials JMIR Research Protocols |
title | Nutritional Interventions for the Prevention of Cognitive Decline in Patients With Mild Cognitive Impairment and Alzheimer Disease: Protocol for a Network Meta-Analysis of Randomized Controlled Trials |
title_full | Nutritional Interventions for the Prevention of Cognitive Decline in Patients With Mild Cognitive Impairment and Alzheimer Disease: Protocol for a Network Meta-Analysis of Randomized Controlled Trials |
title_fullStr | Nutritional Interventions for the Prevention of Cognitive Decline in Patients With Mild Cognitive Impairment and Alzheimer Disease: Protocol for a Network Meta-Analysis of Randomized Controlled Trials |
title_full_unstemmed | Nutritional Interventions for the Prevention of Cognitive Decline in Patients With Mild Cognitive Impairment and Alzheimer Disease: Protocol for a Network Meta-Analysis of Randomized Controlled Trials |
title_short | Nutritional Interventions for the Prevention of Cognitive Decline in Patients With Mild Cognitive Impairment and Alzheimer Disease: Protocol for a Network Meta-Analysis of Randomized Controlled Trials |
title_sort | nutritional interventions for the prevention of cognitive decline in patients with mild cognitive impairment and alzheimer disease protocol for a network meta analysis of randomized controlled trials |
url | https://www.researchprotocols.org/2024/1/e47196 |
work_keys_str_mv | AT qianhe nutritionalinterventionsforthepreventionofcognitivedeclineinpatientswithmildcognitiveimpairmentandalzheimerdiseaseprotocolforanetworkmetaanalysisofrandomizedcontrolledtrials AT kevinchunheiwu nutritionalinterventionsforthepreventionofcognitivedeclineinpatientswithmildcognitiveimpairmentandalzheimerdiseaseprotocolforanetworkmetaanalysisofrandomizedcontrolledtrials AT adamnbennett nutritionalinterventionsforthepreventionofcognitivedeclineinpatientswithmildcognitiveimpairmentandalzheimerdiseaseprotocolforanetworkmetaanalysisofrandomizedcontrolledtrials AT jiayuezhang nutritionalinterventionsforthepreventionofcognitivedeclineinpatientswithmildcognitiveimpairmentandalzheimerdiseaseprotocolforanetworkmetaanalysisofrandomizedcontrolledtrials AT keihangkatiechan nutritionalinterventionsforthepreventionofcognitivedeclineinpatientswithmildcognitiveimpairmentandalzheimerdiseaseprotocolforanetworkmetaanalysisofrandomizedcontrolledtrials |